{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Supportive+Care+Therapy&page=6", "query": { "intervention": "Supportive Care Therapy", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 2961, "total_pages": 297, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Supportive+Care+Therapy&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Supportive+Care+Therapy&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T07:41:44.732Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00996814", "title": "Proactive Ethics Intervention to Improve Intensive Care Unit (ICU) Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intensive Care Unit Days" ], "interventions": [ { "name": "Proactive Ethics Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "California Pacific Medical Center Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 386, "start_date": "2007-10", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2012-01-11", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00996814" }, { "nct_id": "NCT07628192", "title": "Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicidal Ideation", "Suicide Attempt", "Safety Plan", "Depression / Major Depressive Disorder", "Hopelessness" ], "interventions": [ { "name": "CAMS Brief Intervention", "type": "BEHAVIORAL" }, { "name": "Stanley-Brown Safety Planning Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 118, "start_date": "2026-12-01", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07628192" }, { "nct_id": "NCT03778164", "title": "Improving Prevention Systems to Reduce Disparities for High Priority Populations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Fast Track Partner Services-Sexual Health Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Hunter College of City University of New York", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 451, "start_date": "2021-04-01", "completion_date": "2023-10-31", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03778164" }, { "nct_id": "NCT06071858", "title": "Enhanced Coordinated Specialty Care for Early Psychosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychosis", "Schizophrenia", "Schizoaffective Disorder", "Psychosis Nos/Other", "Bipolar Disorder" ], "interventions": [ { "name": "Care Coordination", "type": "BEHAVIORAL" }, { "name": "Individual Peer Support", "type": "BEHAVIORAL" }, { "name": "Digital Outreach", "type": "BEHAVIORAL" }, { "name": "Cognitive Remediation", "type": "BEHAVIORAL" }, { "name": "Multi-Family Group Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Mclean Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 350, "start_date": "2024-02-01", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 5, "location_summary": "Belmont, Massachusetts • Boston, Massachusetts • Cambridge, Massachusetts + 1 more", "locations": [ { "city": "Belmont", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cambridge", "state": "Massachusetts" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06071858" }, { "nct_id": "NCT01965405", "title": "Smoking Cessation for People Living With HIV/AIDS", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV", "AIDS", "Nicotine Dependence" ], "interventions": [ { "name": "Bupropion", "type": "DRUG" }, { "name": "Brief Counseling", "type": "BEHAVIORAL" }, { "name": "High-magnitude prize contingency management", "type": "BEHAVIORAL" }, { "name": "Monitored support to quit smoking", "type": "BEHAVIORAL" }, { "name": "No additional treatment", "type": "BEHAVIORAL" }, { "name": "Prize contingency management for abstinence", "type": "BEHAVIORAL" }, { "name": "Low intensity prize contingency management", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 165, "start_date": "2013-08", "completion_date": "2021-12", "has_results": false, "last_update_posted_date": "2021-07-02", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01965405" }, { "nct_id": "NCT02409342", "title": "A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2015-07-20", "completion_date": "2022-03-08", "has_results": true, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 9, "location_summary": "La Jolla, California • New Haven, Connecticut • Boca Raton, Florida + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT02409342" }, { "nct_id": "NCT04369469", "title": "Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19 Severe Pneumonia", "Acute Lung Injury", "Acute Respiratory Distress Syndrome", "Pneumonia, Viral" ], "interventions": [ { "name": "Ravulizumab", "type": "BIOLOGICAL" }, { "name": "BSC", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 202, "start_date": "2020-05-10", "completion_date": "2021-04-08", "has_results": true, "last_update_posted_date": "2022-05-24", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Orange, California + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04369469" }, { "nct_id": "NCT05520983", "title": "BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental Disabilities (IDD)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Anxiety", "Transition" ], "interventions": [ { "name": "Adapted Teens Achieving Mastery over Stress (TEAMS) Treatment", "type": "BEHAVIORAL" }, { "name": "Adapted Teens Achieving Mastery over Stress (TEAMS) Prevention", "type": "BEHAVIORAL" }, { "name": "Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT)", "type": "BEHAVIORAL" }, { "name": "Strengthening Families", "type": "OTHER" }, { "name": "Virtual psycho-educational discussion groups for caregivers and participants", "type": "OTHER" }, { "name": "Maternal Child Health Bureau (MCHB) Care Coordination", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "13 Years to 20 Years" }, "enrollment_count": 780, "start_date": "2022-09-01", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05520983" }, { "nct_id": "NCT04697524", "title": "Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Advanced Malignant Solid Neoplasm", "Locally Advanced Malignant Solid Neoplasm", "Metastatic Malignant Solid Neoplasm" ], "interventions": [ { "name": "Support Group Therapy", "type": "BEHAVIORAL" }, { "name": "Symptom Management Service (SMS) Consultation", "type": "BEHAVIORAL" }, { "name": "Quality of Life (QOL) Questionnaires", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-01-26", "completion_date": "2023-05-31", "has_results": false, "last_update_posted_date": "2023-08-15", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04697524" }, { "nct_id": "NCT02269280", "title": "Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "Azacitidine (AZA) Days 1 - 3", "type": "DRUG" }, { "name": "Decitabine (DAC)", "type": "DRUG" }, { "name": "Best Supportive Care (BSC)", "type": "OTHER" }, { "name": "Azacitidine (AZA) Days 1 - 5", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 185, "start_date": "2014-10-13", "completion_date": "2024-07-25", "has_results": true, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-10-17T07:41:44.732Z", "location_count": 6, "location_summary": "Tampa, Florida • Baltimore, Maryland • Boston, Massachusetts + 3 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02269280" } ] }